bupropion has been researched along with Anankastic Personality in 5 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We tested the efficacy of bupropion in the treatment of persons with pathological gambling (PG)." | 9.12 | Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study. ( Allen, J; Argo, T; Arndt, S; Black, DW; Coryell, WH; Forbush, KT; Perry, P; Shaw, MC, 2007) |
| "In the present study, we examined the efficacy of bupropion for patients with obsessive-compulsive disorder (OCD)." | 9.11 | Bupropion for patients with obsessive-compulsive disorder: an open-label, fixed-dose study. ( Denys, D; Vulink, NC; Westenberg, HG, 2005) |
| "We tested the efficacy of bupropion in the treatment of persons with pathological gambling (PG)." | 5.12 | Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study. ( Allen, J; Argo, T; Arndt, S; Black, DW; Coryell, WH; Forbush, KT; Perry, P; Shaw, MC, 2007) |
| "In the present study, we examined the efficacy of bupropion for patients with obsessive-compulsive disorder (OCD)." | 5.11 | Bupropion for patients with obsessive-compulsive disorder: an open-label, fixed-dose study. ( Denys, D; Vulink, NC; Westenberg, HG, 2005) |
| "To assess the risk of headache associated with commonly prescribed antidepressant medications and to examine the impact of medication class, pharmacodynamics and dosage on risk of headache." | 2.58 | Meta-analysis: Second generation antidepressants and headache. ( Bloch, MH; Olten, B; Telang, S; Walton, C, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Telang, S | 1 |
| Walton, C | 1 |
| Olten, B | 1 |
| Bloch, MH | 1 |
| Diamond, A | 1 |
| Ondo, WG | 1 |
| Black, DW | 2 |
| Vulink, NC | 1 |
| Denys, D | 1 |
| Westenberg, HG | 1 |
| Arndt, S | 1 |
| Coryell, WH | 1 |
| Argo, T | 1 |
| Forbush, KT | 1 |
| Shaw, MC | 1 |
| Perry, P | 1 |
| Allen, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Bupropion Versus Placebo in the Treatment of Pathological Gambling[NCT00055393] | 80 participants (Actual) | Interventional | 2002-07-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for bupropion and Anankastic Personality
| Article | Year |
|---|---|
Meta-analysis: Second generation antidepressants and headache.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Bupropion; Citalopram; Depression; Double- | 2018 |
3 trials available for bupropion and Anankastic Personality
| Article | Year |
|---|---|
An open-label trial of bupropion in the treatment of pathologic gambling.
Topics: Administration, Oral; Adult; Bupropion; Delayed-Action Preparations; Drug Administration Schedule; F | 2004 |
Bupropion for patients with obsessive-compulsive disorder: an open-label, fixed-dose study.
Topics: Adult; Ambulatory Care; Bupropion; Delayed-Action Preparations; Dopamine; Dopamine Uptake Inhibitors | 2005 |
Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Bupropion; Diagnostic and Statistical Manu | 2007 |
1 other study available for bupropion and Anankastic Personality
| Article | Year |
|---|---|
Resolution of severe obsessive--compulsive disorder after a small unilateral nondominant frontoparietal infarct.
Topics: Adult; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Brai | 2011 |